AEON Stock Summary and Trading Ideas (Aeon Biopharma Class A | AMEX:AEON)

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Aeon Biopharma Class A trades on the AMEX stock market under the symbol AEON.

As of August 31, 2026, AEON stock price declined to $0.30 with 431,204 million shares trading.

AEON has a beta of -0.24, meaning it tends to be less sensitive to market movements. AEON has a correlation of 0.00 to the broad based SPY ETF.

AEON has a market cap of $14.76 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AEON traded as high as $1,236.24 and as low as $.18.

The top ETF exchange traded funds that AEON belongs to (by Net Assets): VXF.

AEON has underperformed the market in the last year with a return of -62.0%, while the SPY ETF gained +19.4%. In the last 3 month period, AEON fell short of the market, returning -58.7%, while SPY returned +1.9%. However, in the most recent 2 weeks AEON has outperformed the stock market by returning +7.6%, while SPY returned -1.2%.

AEON support price is $.29 and resistance is $.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEON shares will trade within this expected range on the day.